chrysophanic acid has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, G; He, W; Jiang, F; Jiang, J; Li, R; Meng, L; Shi, Y; Tan, S; Wang, M; Xu, N; Zhao, Y | 1 |
| Li, A; Lin, Z; Liu, Y; Wang, L; Wang, S; Zhai, L | 1 |
2 other study(ies) available for chrysophanic acid and Lung Injury, Acute
| Article | Year |
|---|---|
Chrysophanol alleviates acute lung injury caused by Klebsiella pneumoniae infection by inhibiting pro-inflammatory cytokine production.
Topics: Acute Lung Injury; Animals; Anthraquinones; Cytokines; Inflammasomes; Klebsiella pneumoniae; Lipopolysaccharides; Lung; Mice; NF-kappa B; Toll-Like Receptor 4 | 2023 |
Activating Peroxisome Proliferator-Activated Receptors (PPARs): a New Sight for Chrysophanol to Treat Paraquat-Induced Lung Injury.
Topics: Acute Lung Injury; Animals; Anthraquinones; Bronchoalveolar Lavage Fluid; Dexamethasone; Herbicides; Inflammation; Interleukin-1beta; Interleukin-6; Lung; Malondialdehyde; Mice, Inbred BALB C; NF-kappa B; Paraquat; Peroxidase; PPAR gamma; Pulmonary Edema; Random Allocation; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2016 |